Scleroderma Latest Advances

Find the Latest Research About Scleroderma

Last Updated: 11/08/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32948 publications

Pirfenidone-loaded hyaluosomes as a nanocarrier for the treatment of scleroderma.

Pirfenidone-loaded hyaluosomes as a nanocarrier for the treatment of scleroderma.

Journal: Pharmaceutical development and technology
Published: October 30, 2026

ANA Testing From Background Prevalence to Pretest Probability: A Recommendation for Routine Practice.

ANA Testing From Background Prevalence to Pretest Probability: A Recommendation for Routine Practice.

Journal: Deutsches Arzteblatt international
Published: October 29, 2026

Macrophage heterogeneity and interferon signaling in systemic sclerosis.

Macrophage heterogeneity and interferon signaling in systemic sclerosis.

Journal: Current opinion in rheumatology
Published: October 27, 2026

Conserved Fibroblast Subsets Drive Shared Fibrotic Mechanisms in Osteoarthritis Synovium and Systemic Sclerosis Skin.

Conserved Fibroblast Subsets Drive Shared Fibrotic Mechanisms in Osteoarthritis Synovium and Systemic Sclerosis Skin.

Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026

A mast cell receptor is associated with fibrosis and itch in systemic sclerosis.

A mast cell receptor is associated with fibrosis and itch in systemic sclerosis.

Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026

Hallmarks of aging in systemic sclerosis: implications for pathogenesis, multimorbidity, and therapeutic development.

Hallmarks of aging in systemic sclerosis: implications for pathogenesis, multimorbidity, and therapeutic development.

Journal: EULAR rheumatology open
Published: October 25, 2026

Systemic sclerosis markedly impairs health-related quality of life: a single-centre tertiary cohort study with literature-based comparison to leading causes of global disease burden.

Systemic sclerosis markedly impairs health-related quality of life: a single-centre tertiary cohort study with literature-based comparison to leading causes of global disease burden.

Journal: Journal of global health
Published: October 24, 2026

Health literacy level and influencing factors among the French Scleroderma Association (ASF) members: a cross-sectional survey.

Health literacy level and influencing factors among the French Scleroderma Association (ASF) members: a cross-sectional survey.

Journal: BMJ open
Published: October 23, 2026

Systemic sclerosis in 2026: emerging paradigms from the World Scleroderma Congress.

Systemic sclerosis in 2026: emerging paradigms from the World Scleroderma Congress.

Journal: Current opinion in rheumatology
Published: October 19, 2026

Connective tissue disease-associated interstitial lung disease: immune profiling and correlation of immune cells with pulmonary function in SSc-ILD.

Connective tissue disease-associated interstitial lung disease: immune profiling and correlation of immune cells with pulmonary function in SSc-ILD.

Journal: Annals of medicine
Published: October 15, 2026

Systemic sclerosis with anti-human neutrophil cytoplasm antibody associated vasculitis: A case report

Systemic sclerosis with anti-human neutrophil cytoplasm antibody associated vasculitis: A case report

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: October 15, 2026

Impact of timing of interstitial lung disease in patients with systemic sclerosis.

Impact of timing of interstitial lung disease in patients with systemic sclerosis.

Journal: Thorax
Published: October 13, 2026
Showing 1-12 of 32,948

Last Updated: 11/08/2026